NaDeNo seeks funding ahead of clinical entry
Nordic Life Science Days With a base at AstraZeneca’s [...]
NaDeNo Presents at GoCo Investor Day
Organized by GoCo Health Innovation City and AstraZeneca’s BioVentureHub [...]
NaDeNo joins AstraZeneca BioVentureHub
We are proud to announce that NaDeNo Nanoscience AS has [...]
NaDeNo Welcomes Dr. Jens Bjørheim as Chief Medical Officer
We’re excited to welcome Jens Bjørheim to the NaDeNo team [...]
Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models
Read the full publication here What you’ll learn in this [...]
